Journal of International Oncology››2014,Vol. 41››Issue (10): 767-770.doi:10.3760/cma.j.issn.1673422X.2014.10.015

Previous ArticlesNext Articles

Research progress of immunohistochemical markers related with pancreatic cancer prognosis

ZHU Peng, LIU Hui-Ying, HU Zhi-Qian, WANG Wei-Jun

  1. Department of General Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
  • Online:2014-10-29Published:2014-10-11
  • Contact:WangWeijun E-mail:610207494@qq.com

Abstract:Pancreatic cancer is a malignant with very poor prognosis. Although methods and technologies of diagnosis and treatment in connection with pancreatic cancer have made great progresses, the prognoses of patients with pancreatic cancer still have not a significant upgrade, which are closely related with the degree of malignancy of pancreatic cancer cells. Earlier studies have shown that normal pancreatic cells need to have a total of six capabilities, which are intimate connection with the degree of malignancy of pancreatic cancer cells, during the process of deterioration. A variety of immunohistochemical markers that correlate with prognosis of pancreatic cancer involve in the process of pancreatic cells obtaining these six capabilities.

Key words:Pancreatic neoplasms,Prognosis,Tumor markers,biological